| 영문 | embryonal carcinoma | 한글 | 배아암종 |
|---|---|---|---|
| 설명 | 생식세포에서 생기는 암종의 하나로 대부분 고환에서 발생한다. 드물게는 종격동에서도 발생한다. 40~50대의 남성에게 많으나, 이보다 낮은 연령층에서도 나타난다. 육안적으로는 회백색의 분엽을 보이는 덩어리를 형성하며, 고환 악성 종양 중 예후가 좋은 편이다. 치료의 원칙은 가급적 신속하게 원발소를 절제하고 예상되는 전이병터에 대하여 방사선 조사요법을 행해야 한다. 태생암종 방사선요법에 대하여 매우 감수성이 높기 때문에 병기가 초기이면 90% 이상의 치료가 기대된다. 그리고 화학요법제에 의해 그 치료성과가 상승하고 있다. |
||
| 영문 | carcinoma in situ | 한글 | 상피내암종 |
|---|---|---|---|
| 설명 | 신체의 내부나 외부를 쌓고 있는 조직을 상피라고 한다. 이 상피의 아래에는 대개 상피를 지지하고 있는 조직의 위에 존재한다. 그리고 이 지지조직과 상피 사이에는 기저막이라는 막이 있어서 상피와 지지조직을 구분해 준다. 암종(carcinoma)란 상피의 세포가 악성 변화를 하여 생기는 암을 말한다. 제자리암종이란 암종의 한 종류로 암종이 기저막을 벗어나지 못하고 상피내 즉, 제자리에 머물러 있는 경우를 말한다. |
||
| 영문 | carcinoma | 한글 | 암종 |
|---|---|---|---|
| 설명 | 암종이란 상피세포(-신체의 내부나 외부를 쌓고 있는 조직을 상피라고 하고, 상피를 이루고 있는 세포를 상피세포라고 한다)의 과도한 증식에의한 악성종양을 이르는 말이다. |
||
| 영문 | renal cell carcinoma | 한글 | 콩팥세포암종 |
|---|---|---|---|
| 설명 | 콩팥에 생긴 원시콩팥조직에서 발생한 암. 주로 원시세뇨관조직에서 발생한다. 대표적인 세포조직형은 염색시 세포질이 맑게 비어보이는 맑은세포암종이다. 치료는 수술과 항암화학요법이며 아주 드물지만 저절로 낫는 경우도 있는 것으로 보고되어 있다. |
||
| 영문 | squamous cell carcinoma | 한글 | 편평세포암종 |
|---|---|---|---|
| 설명 | 편평세포 기원의 암으로서, 편평세포가 있는 어떤 곳에서든 발생가능함. 따라서 식도암, 피부암, 폐암, 자궁암 등이 여기에 해당된다. 특히 피부암은 많은 자외선조사에 의해 생기는 광선각화증에서 발생가능하다. 병리조직학적 특성으로서 각질을 생성한다. |
||
| HRP | high-risk patient; high-risk pregnancy; histidine-rich protein; horseradish peroxidase |
|---|---|
| RR | radiation reaction; radiation response; rate ratio; rational recovery [group]; recovery room; relati... |
| 131I | radioactive Iodine(used in Thyroid uptake, Liver & Kidney Scans & Treatment of malignant & nonmalig... |
| MEN | Multiple Endocrine Neoplasia ; AD Trait 1. MEN Type I(= Wermer Syndro... |
| HTS | head traumatic syndrome; HeLa tumor suppression; human thyroid-stimulating hormone, human thyroid st... |
| risk benefit | An analysis of risk versus benefit is a complex assessment that must be made by a physician prior to the administration of a particular form of drug therapy. Since many medications may have side effects that can be harmful (during the course of treatment), the overall risk of a particular form of drug therapy must be weighed against the overall threat of the untreated disease process (or treatment with an altenative drug). (27 Sep 1997) |
|---|---|
| risk factor | <statistics> A clearly defined occurrence or characteristic that has been associated with the increased rate of a subsequently occurring disease. (14 Oct 1997) |
| risk management | The process of minimizing risk to an organization by developing systems to identify and analyze potential hazards to prevent accidents, injuries, and other adverse occurrences, and by attempting to handle events and incidents which do occur in such a manner that their effect and cost are minimised. Effective risk management has its greatest benefits in application to insurance in order to avert or minimise financial liability. (12 Dec 1998) |
| risk of recurrence | In medical genetics, the chance that a genetic (inherited) disease present in a family will recur in that family. The concept in general medicine means the chance that an illness we come back again. (12 Dec 1998) |
| risk patient | Patient who is at risk, because of his/her behaviour or because of the type of person he/she is. (18 Nov 1997) |
| risk reduction | Techniques used to reduce your chances of getting a certain cancer. For example: reducing your dietary fat may help prevent breast cancer. (09 Oct 1997) |
| risk-taking | Undertaking a task involving a challenge for achievement or a desirable goal in which there is a lack of certainty or a fear of failure. It may also include the exhibiting of certain behaviours whose outcomes may present a risk to the individual or to those associated with him or her. (12 Dec 1998) |
| competing risk | An event that removes a subject from being at risk for an outcome under investigation. (05 Mar 2000) |
| pregnancy, high-risk | Pregnancy in which the mother and/or foetus are at greater than normal risk of morbidity or mortality. Causes include lack of adequate prenatal care, previous obstetrical history, pre-existing maternal disease or pregnancy-induced disease, and multiple gestation, as well as advanced maternal age. (12 Dec 1998) |
| health risk assessment | Method of describing an individual's chance of falling ill or dying of a specified condition, based on actuarial calculations that allow for known exposure to risk; expressed as expected age at which death or disease will occur, and intended as a way of drawing an individual's attention to the probable consequences of risk behaviour. (05 Mar 2000) |
| empiric risk | The chance that a disease will occur in a family based upon experience (past history, medical records, etc.) rather than theory. (12 Dec 1998) |
| age factors | Age as a constituent element or influence contributing to the production of a result. It may be applicable to the cause or the effect of a circumstance. It is used with human or animal concepts but should be differentiated from aging, a physiological process, and time factors which refers only to the passage of time. (12 Dec 1998) |
| bacteriocin factors | Bacterial plasmid's responsible for the elaboration of bacteriocins. Synonym: bacteriocin factors, bacteriocinogens. (05 Mar 2000) |
| B-cell differentiation/growth factors | Various substances, usually obtained from the supernatant of T-cell cultures, such as interleukin 4, 5, and 6. These substances are necessary for B-cell growth, maturation, and differentiation into plasma cells or B memory cells. (05 Mar 2000) |
| biological factors | Compounds made by living organisms. They have biological or physiological activities. (12 Dec 1998) |